Zacks: Brokerages Anticipate National Health Investors Inc (NHI) Will Post Earnings of $1.32 Per Share

Share on StockTwits

Analysts expect National Health Investors Inc (NYSE:NHI) to announce earnings per share (EPS) of $1.32 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for National Health Investors’ earnings, with estimates ranging from $1.27 to $1.37. National Health Investors posted earnings per share of $1.35 during the same quarter last year, which would indicate a negative year over year growth rate of 2.2%. The firm is expected to report its next quarterly earnings report on Tuesday, May 14th.

On average, analysts expect that National Health Investors will report full year earnings of $5.50 per share for the current fiscal year, with EPS estimates ranging from $5.43 to $5.63. For the next fiscal year, analysts forecast that the firm will report earnings of $5.72 per share, with EPS estimates ranging from $5.65 to $5.76. Zacks’ EPS averages are a mean average based on a survey of sell-side research firms that cover National Health Investors.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, February 19th. The real estate investment trust reported $0.87 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.39 by ($0.52). The company had revenue of $74.00 million during the quarter, compared to the consensus estimate of $75.16 million. National Health Investors had a return on equity of 11.36% and a net margin of 52.38%. National Health Investors’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.35 EPS.

NHI has been the subject of a number of recent research reports. Zacks Investment Research raised shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, February 28th. ValuEngine raised shares of National Health Investors from a “hold” rating to a “buy” rating in a research report on Tuesday, December 11th. BMO Capital Markets downgraded shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $78.00 price objective for the company. in a research report on Wednesday, February 20th. KeyCorp set a $65.00 price objective on shares of National Health Investors and gave the company a “sell” rating in a research report on Thursday, December 20th. Finally, SunTrust Banks boosted their price objective on shares of National Health Investors to $85.00 and gave the company a “neutral” rating in a research report on Wednesday, February 20th. They noted that the move was a valuation call. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the stock. National Health Investors currently has an average rating of “Hold” and an average price target of $78.14.

Shares of NYSE:NHI opened at $79.24 on Friday. The company has a quick ratio of 17.92, a current ratio of 17.92 and a debt-to-equity ratio of 0.92. National Health Investors has a fifty-two week low of $65.10 and a fifty-two week high of $84.57. The stock has a market cap of $3.37 billion, a P/E ratio of 14.46 and a beta of 0.51.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Friday, March 29th will be given a dividend of $1.05 per share. This represents a $4.20 dividend on an annualized basis and a dividend yield of 5.30%. The ex-dividend date is Thursday, March 28th. This is an increase from National Health Investors’s previous quarterly dividend of $1.00. National Health Investors’s dividend payout ratio is currently 72.99%.

In related news, Director Robert A. Mccabe, Jr. sold 1,181 shares of the business’s stock in a transaction dated Thursday, February 21st. The shares were sold at an average price of $78.04, for a total transaction of $92,165.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 5.63% of the stock is owned by corporate insiders.

Institutional investors have recently bought and sold shares of the business. ERTS Wealth Advisors LLC acquired a new position in National Health Investors during the 4th quarter valued at about $25,000. Oppenheimer Asset Management Inc. acquired a new position in National Health Investors during the 4th quarter valued at about $52,000. Quantamental Technologies LLC acquired a new position in National Health Investors during the 4th quarter valued at about $75,000. Doyle Wealth Management acquired a new position in National Health Investors during the 4th quarter valued at about $76,000. Finally, MML Investors Services LLC acquired a new position in National Health Investors during the 3rd quarter valued at about $212,000. 70.77% of the stock is owned by hedge funds and other institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Read More: Balance Sheet

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Dimensional Fund Advisors LP Decreases Holdings in Gannett Co Inc
Dimensional Fund Advisors LP Decreases Holdings in Gannett Co Inc
Restoration Robotics’  Hold Rating Reaffirmed at Maxim Group
Restoration Robotics’ Hold Rating Reaffirmed at Maxim Group
Itau Unibanco Holding SA  Stake Lowered by Bp Plc
Itau Unibanco Holding SA Stake Lowered by Bp Plc
HC Wainwright Reaffirms “Buy” Rating for Blink Charging
HC Wainwright Reaffirms “Buy” Rating for Blink Charging
Deutsche Bank AG Sells 703,201 Shares of Golden Star Resources Ltd.
Deutsche Bank AG Sells 703,201 Shares of Golden Star Resources Ltd.
Hilton Hotels Co.  Position Lifted by Dimensional Fund Advisors LP
Hilton Hotels Co. Position Lifted by Dimensional Fund Advisors LP


© 2006-2019 Ticker Report